Chinese Biotech Firm Leto Lab Secures RMB100 Million

This Data Is Locked!

This area is available only to Subscribers.

Leto Lab, a biotechnology focused on recobinant protein drugs, has recently completed a series B financing of over RMB100 million yuan. This round of financing... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?